Breaking barriers - Attack on innate immune defences by omptin surface proteases of enterobacterial pathogens

Innate Immunity

Volumn 15, Issue 2, 2009, Pages 67-80

  Haiko, Johanna ^a   Suomalainen, Marjo ^a   Ojala, Teija ^a   Lähteenmäki, Kaarina ^b   Korhonen, Timo K ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b FINNISH RED CROSS BLOOD SERVICE   (Finland)

Author keywords

Antimicrobial peptides; Escherichia coli; Gelatinase; Plague; Plasminogen activator; Salmonellosis; Surface proteolysis

Indexed keywords

ASPARTIC PROTEINASE; BACTERIUM LIPOPOLYSACCHARIDE; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MATRIX METALLOPROTEINASE; OMPTIN; PLASMIN; PLASMINOGEN; POLYPEPTIDE ANTIBIOTIC AGENT; TOLL LIKE RECEPTOR 4; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL PROTEIN; ESCHERICHIA COLI PROTEIN; LIPOPOLYSACCHARIDE; MEMBRANE PROTEIN; OMPT PROTEIN, E COLI; PEPTIDE HYDROLASE; PGTE PROTEIN, SALMONELLA ENTERICA; PLA PROTEASE, YERSINIA PESTIS; PLASMINOGEN ACTIVATOR; PROTEINASE;

BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL INFECTION; CELL INTERACTION; COMPLEMENT INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBRINOLYSIS; GENE LOSS; GENETIC CONSERVATION; GRAM NEGATIVE BACTERIUM; HUMAN; IN VIVO STUDY; INNATE IMMUNITY; NONHUMAN; PATHOGENESIS; PATHOGENIC ESCHERICHIA COLI; PROTEIN DEGRADATION; PROTEIN FUNCTION; REVIEW; SALMONELLA ENTERICA; SPECIES DIFFERENCE; YERSINIA PESTIS; ANIMAL; BACTERIUM ADHERENCE; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTION; ENZYMOLOGY; GENETIC VARIABILITY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HOST PATHOGEN INTERACTION; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; PATHOGENICITY; PATHOPHYSIOLOGY; PROTEIN CONFORMATION;

BACTERIA (MICROORGANISMS); ENTEROBACTERIACEAE; ESCHERICHIA COLI; NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; YERSINIA PESTIS;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL ADHESION; BACTERIAL PROTEINS; ENDOPEPTIDASES; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; ENZYME ACTIVATION; ESCHERICHIA COLI PROTEINS; EVOLUTION, MOLECULAR; GENETIC VARIATION; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; LIPOPOLYSACCHARIDES; MEMBRANE PROTEINS; PEPTIDE HYDROLASES; PLASMINOGEN ACTIVATORS; PROTEIN CONFORMATION;

EID: 63349105215     PISSN: 17534259     EISSN: 17534267     Source Type: Journal    
DOI: 10.1177/1753425909102559     Document Type: Review

References (122)

1. Herwald H., Morgelin M., Olsen A. et al. Activation of the contact-phase system on bacterial surfaces - a clue to serious complications in infectious diseases. Nat Med 1998; 4: 298-302.
2. Lähteenmäki K., Edelman S., Korhonen TK Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol 2005; 13: 79-85.
3. Foster TJ Immune evasion by staphylococci. Nat Rev Microbiol 2005; 3: 948-958.
4. Bergmann S., Hammerschmidt S. Fibrinolysis and host response in bacterial infections. Thromb Haemost 2007; 98: 512-520.
5. Lähteenmäki K., Kuusela P., Korhonen TK Bacterial plasminogen activators and receptors. FEMS Microbiol Rev 2001; 25: 531-552.
6. Rawlings ND, Morton FR, Kok CY, Kong J., Barrett AJ MEROPS: The peptidase database. Nucleic Acids Res 2008; 36: D320-D325.
7. Prentice MB, Rahalison L. Plague. Lancet 2007; 369: 1196-1207.
8. Brubaker RR, Beesley ED, Surgalla MJ Pasteurella pestis: Role of pesticin I and iron in experimental plague. Science 1965; 149: 422-424.
9. Anisimov AP, Lindler LE, Pier GB Intraspecific diversity of Yersinia pestis. Clin Microbiol Rev 2004; 17: 434-464.
10. Sebbane F., Jarrett CO, Gardner D., Long D., Hinnebusch BJ Role of the Yersinia pestis plasminogen activator in the incidence of distinct septicemic and bubonic forms of flea-borne plague. Proc Natl Acad Sci USA 2006; 103: 5526-5530.
11. Sodeinde OA, Subrahmanyam YV, Stark K., Quan T., Bao Y., Goguen JD A surface protease and the invasive character of plague. Science 1992; 258: 1004-1007.
12. Lathem WW, Price PA, Miller VL, Goldman WE A plasminogen-activating protease specifically controls the development of primary pneumonic plague. Science 2007; 315: 509-513.
13. Ohl ME, Miller SI Salmonella: A model for bacterial pathogenesis. Annu Rev Med 2001; 52: 259-274.
14. Lähteenmäki K., Kyllönen P., Partanen L., Korhonen TK Antiprotease inactivation by Salmonella enterica released from infected macrophages. Cell Microbiol 2005; 7: 529-538.
15. Ramu P., Tanskanen R., Holmberg M., Lähteenmäki K., Korhonen TK, Meri S. The surface protease PgtE of Salmonella enterica affects complement activity by proteolytically cleaving C3b, C4b and C5. FEBS Lett 2007; 581: 1716-1720.
16. Ramu P., Lobo LA, Kukkonen M. et al. Activation of pro-matrix metalloproteinase-9 and degradation of gelatin by the surface protease PgtE of Salmonella enterica serovar Typhimurium. Int J Med Microbiol 2008; 298: 263-278.
17. Kaper JB, Nataro JP, Mobley HL Pathogenic Escherichia coli. Nat Rev Microbiol 2004; 2: 123-140.
18. Kukkonen M., Korhonen TK The omptin family of enterobacterial surface proteases/adhesins: From housekeeping in Escherichia coli to systemic spread of Yersinia pestis. Int J Med Microbiol 2004; 294: 7-14.
19. Hritonenko V., Stathopoulos C. Omptin proteins: An expanding family of outer membrane proteases in Gram-negative Enterobacteriaceae. Mol Membr Biol 2007; 24: 395-406.
20. Kukkonen M., Lähteenmäki K., Suomalainen M. et al. Protein regions important for plasminogen activation and inactivation of alpha2-antiplasmin in the surface protease Pla of Yersinia pestis. Mol Microbiol 2001; 40: 1097-1111.
21. Kukkonen M., Suomalainen M., Kyllonen P. et al. Lack of O-antigen is essential for plasminogen activation by Yersinia pestis and Salmonella enterica. Mol Microbiol 2004; 51: 215-225.
22. Sodeinde OA, Goguen JD Genetic analysis of the 9.5-kilobase virulence plasmid of Yersinia pestis. Infect Immun 1988; 56: 2743-2748.
23. Nakata N., Tobe T., Fukuda I. et al. The absence of a surface protease, OmpT, determines the intercellular spreading ability of Shigella: The relationship between the ompT and kcpA loci. Mol Microbiol 1993; 9: 459-468.
24. Grodberg J., Dunn JJ Comparison of Escherichia coli K-12 outer membrane protease OmpT and Salmonella typhimurium E protein. J Bacteriol 1989; 171: 2903-2905.
25. Sodeinde OA, Goguen JD Nucleotide sequence of the plasminogen activator gene of Yersinia pestis: Relationship to ompT of Escherichia coli and gene E of Salmonella typhimurium. Infect Immun 1989; 57: 1517-1523.
26. Suomalainen M., Haiko J., Ramu P. et al. Using every trick in the book: the Pla surface protease of Yersinia pestis. Adv Exp Med Biol 2007; 603: 268-278.
27. Achtman M., Aurth K., Morelli G., Torrea G., Guiyoule A., Carniel E. Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proc Natl Acad Sci USA 1999; 96: 14043-14048.
28. Achtman M., Morelli G., Zhu P. et al. Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci USA 2004; 101: 17837-17842.
29. Ochman H., Wilson AC Evolution in bacteria: Evidence for a universal substitution rate in cellular genomes. J Mol Evol 1987; 26: 74-86.
30. Wren BW The yersiniae - a model genus to study the rapid evolution of bacterial pathogens. Nat Rev Microbiol 2003; 1: 55-64.
31. Vandeputte-Rutten L., Kramer RA, Kroon J., Dekker N., Egmond MR, Gros P. Crystal structure of the outer membrane protease OmpT from Escherichia coli suggests a novel catalytic site. EMBO J 2001; 20: 5033-5039.
32. Kramer RA, Zandwijken D., Egmond MR, Dekker N. In vitro folding, purification and characterization of Escherichia coli outer membrane protease OmpT. Eur J Biochem 2000; 267: 885-893.
33. Dixon DR, Darveau RP Lipopolysaccharide heterogeneity: Innate host responses to bacterial modification of lipid a structure. J Dent Res 2005; 84: 584-595.
34. Lerouge I., Vanderleyden J. O-antigen structural variation: Mechanisms and possible roles in animal/plant-microbe interactions. FEMS Microbiol Rev 2002; 26: 17-47.
35. Miller SI, Ernst RK, Bader MW LPS, TLR4 and infectious disease diversity. Nat Rev Microbiol 2005; 3: 36-46.
36. Ferguson AD, Welte W., Hofmann E. et al. A conserved structural motif for lipopolysaccharide recognition by prokaryotic and eukaryotic proteins. Structure 2000; 8: 585-592.
37. Visintin A., Latz E., Monks BG, Espevik T., Golenbock DT Lysines 128 and 132 enable lipopolysaccharide binding to MD-2, leading to Toll-like receptor-4 aggregation and signal transduction. J Biol Chem 2003; 278: 48313-48320.
38. Ferguson AD, Hofmann E., Coulton JW, Diederichs K., Welte W. Siderophore-mediated iron transport: Crystal structure of FhuA with bound lipopolysaccharide. Science 1998; 282: 2215-2220.
39. Kramer RA, Brandenburg K., Vandeputte-Rutten L. et al. Lipopolysaccharide regions involved in the activation of Escherichia coli outer membrane protease OmpT. Eur J Biochem 2002; 269: 1746-1752.
40. Skurnik M., Peippo A., Ervela E. Characterization of the O-antigen gene clusters of Yersinia pseudotuberculosis and the cryptic O-antigen gene cluster of Yersinia pestis shows that the plague bacillus is most closely related to and has evolved from Y. pseudotuberculosis serotype O:1B. Mol Microbiol 2000; 37: 316-330.
41. al-Hendy A., Toivanen P., Skurnik M. Lipopolysaccharide O side chain of Yersinia enterocolitica O:3 is an essential virulence factor in an orally infected murine model. Infect Immun 1992; 60: 870-875.
42. Darwin AJ, Miller VL Identification of Yersinia enterocolitica genes affecting survival in an animal host using signature-tagged transposon mutagenesis. Mol Microbiol 1999; 32: 51-62.
43. Rautemaa R., Meri S. Complement-resistance mechanisms of bacteria. Microbes Infect 1999; 1: 785-794.
44. Bengoechea JA, Najdenski H., Skurnik M. Lipopolysaccharide O antigen status of Yersinia enterocolitica O:8 is essential for virulence and absence of O antigen affects the expression of other Yersinia virulence factors. Mol Microbiol 2004; 52: 451-469.
45. Skurnik M., Biedzka-Sarek M., Lubeck PS et al. Characterization and biological role of the O-polysaccharide gene cluster of Yersinia enterocolitica serotype O:9. J Bacteriol 2007; 189: 7244-7253.
46. Porat R., McCabe WR, Brubaker RR Lipopolysaccharide-associated resistance to killing of yersiniae by complement. J Endotoxin Res 1995; 2: 91-97.
47. Peterson AA, McGroarty EJ High-molecular-weight components in lipopolysaccharides of Salmonella typhimurium, Salmonella minnesota, and Escherichia coli. J Bacteriol 1985; 162: 738-745.
48. Batchelor RA, Haraguchi GE, Hull RA, Hull SI Regulation by a novel protein of the bimodal distribution of lipopolysaccharide in the outer membrane of Escherichia coli. J Bacteriol 1991; 173: 5699-5704.
49. Bastin DA, Stevenson G., Brown PK, Haase A., Reeves PR Repeat unit polysaccharides of bacteria: A model for polymerization resembling that of ribosomes and fatty acid synthetase, with a novel mechanism for determining chain length. Mol Microbiol 1993; 7: 725-734.
50. Murray GL, Attridge SR, Morona R. Regulation of Salmonella typhimurium lipopolysaccharide O antigen chain length is required for virulence; identification of FepE as a second Wzz. Mol Microbiol 2003; 47: 1395-1406.
51. Eriksson S., Lucchini S., Thompson A., Rhen M., Hinton JC Unravelling the biology of macrophage infection by gene expression profiling of intracellular Salmonella enterica. Mol Microbiol 2003; 47: 103-118.
52. Guo L., Lim KB, Gunn JS et al. Regulation of lipid A modifications by Salmonella typhimurium virulence genes phoP-phoQ. Science 1997; 276: 250-253.
53. Baker SJ, Gunn JS, Morona R. The Salmonella typhi melittin resistance gene pqaB affects intracellular growth in PMAdifferentiated U937 cells, polymyxin B resistance and lipopolysaccharide. Microbiology 1999; 145: 367-378.
54. Kawasaki K., Ernst RK, Miller SI 3-O-Deacylation of lipid A by PagL, a PhoP/PhoQ-regulated deacylase of Salmonella typhimurium, modulates signaling through Toll-like receptor 4. J Biol Chem 2004; 279: 20044-20048.
55. Darveau RP, Charnetzky WT, Hurlbert RF, Hancock RE Effects of growth temperature, 47-megadalton plasmid, and calcium deficiency on the outer membrane protein porin and lipopolysaccharide composition of Yersinia pestis EV76. Infect Immun 1983; 42: 1092-1101.
56. Kawahara K., Tsukano H., Watanabe H., Lindner B., Matsuura M. Modification of the structure and activity of lipid A in Yersinia pestis lipopolysaccharide by growth temperature. Infect Immun 2002; 70: 4092-4098.
57. Rebeil R., Ernst RK, Gowen BB, Miller SI, Hinnebusch BJ Variation in lipid A structure in the pathogenic yersiniae. Mol Microbiol 2004; 52: 1363-1373.
58. Knirel YA, Dentovskaya SV, Senchenkova SN, Shaikhutdinova RZ, Kocharova NA, Anisimov AP Structural features and structural variability of the lipopolysaccharide of Yersinia pestis, the cause of plague. J Endotoxin Res 2006; 12: 3-9.
59. Rebeil R., Ernst RK, Jarrett CO, Adams KN, Miller SI, Hinnebusch BJ Characterization of late acyltransferase genes of Yersinia pestis and their role in temperature-dependent lipid A variation. J Bacteriol 2006; 188: 1381-1388.
60. Knirel YA, Lindner B., Vinogradov EV et al. Temperature-dependent variations and intraspecies diversity of the structure of the lipopolysaccharide of Yersinia pestis. Biochemistry 2005; 44: 1731-1743.
61. Dentovskaya SV, Bakhteeva IV, Titareva GM et al. Structural diversity and endotoxic activity of the lipopolysaccharide of Yersinia pestis. Biochemistry (Mosc) 2008; 73: 192-199.
62. Rietschel ET, Brade L., Brandenburg K. et al. Chemical structure and biologic activity of bacterial and synthetic lipid A. Rev Infect Dis 1987; 9(Suppl 5): S527-S536.
63. Montminy SW, Khan N., McGrath S. et al. Virulence factors of Yersinia pestis are overcome by a strong lipopolysaccharide response. Nat Immunol 2006; 7: 1066-1073.
64. Bengoechea JA, Brandenburg K., Arraiza MD, Seydel U., Skurnik M., Moriyon I. Pathogenic Yersinia enterocolitica strains increase the outer membrane permeability in response to environmental stimuli by modulating lipopolysaccharide fluidity and lipid A structure. Infect Immun 2003; 71: 2014-2021.
65. Kim TJ, Chauhan S., Motin VL, Goh EB, Igo MM, Young GM Direct transcriptional control of the plasminogen activator gene of Yersinia pestis by the cyclic AMP receptor protein. J Bacteriol 2007; 189: 8890-8900.
66. Deng W., Burland V., Plunkett 3rd G. et al. Genome sequence of Yersinia pestis KIM. J Bacteriol 2002; 184: 4601-4611.
67. Chromy BA, Choi MW, Murphy GA et al. Proteomic characterization of Yersinia pestis virulence. J Bacteriol 2005; 187: 8172-8180.
68. Chauvaux S., Rosso ML, Frangeul L. et al. Transcriptome analysis of Yersinia pestis in human plasma: An approach for discovering bacterial genes involved in septicaemic plague. Microbiology 2007; 153: 3112-3124.
69. Cavanaugh DC Specific effect of temperature upon transmission of the plague bacillus by the oriental rat flea, Xenopsylla cheopis. Am J Trop Med Hyg 1971; 20: 264-272.
70. McDonough KA, Falkow S. A Yersinia pestis-specific DNA fragment encodes temperature-dependent coagulase and fibrinolysin-associated phenotypes. Mol Microbiol 1989; 3: 767-775.
71. Navarre WW, Halsey TA, Walthers D. et al. Co-regulation of Salmonella enterica genes required for virulence and resistance to antimicrobial peptides by SlyA and PhoP/PhoQ. Mol Microbiol 2005; 56: 492-508.
72. Alpuche Aranda CM, Swanson JA, Loomis WP, Miller SI Salmonella typhimurium activates virulence gene transcription within acidified macrophage phagosomes. Proc Natl Acad Sci USA 1992; 89: 10079-10083.
73. Hautefort I., Thompson A., Eriksson-Ygberg S. et al. During infection of epithelial cells Salmonella enterica serovar Typhimurium undergoes a time-dependent transcriptional adaptation that results in simultaneous expression of three type 3 secretion systems. Cell Microbiol 2008; 10: 958-984.
74. White CB, Chen Q., Kenyon GL, Babbitt PC A novel activity of OmpT. Proteolysis under extreme denaturing conditions. J Biol Chem 1995; 270: 12990-12994.
75. Baev MV, Baev D., Radek AJ, Campbell JW Growth of Escherichia coli MG1655 on LB medium: Monitoring utilization of amino acids, peptides, and nucleotides with transcriptional microarrays. Appl Microbiol Biotechnol 2006; 71: 317-322.
76. Li H., Wang BC, Xu WJ, Lin XM, Peng XX Identification and network of outer membrane proteins regulating streptomycin resistance in Escherichia coli. J Proteome Res 2008; 7: 4040-4049.
77. Lijnen HR, Collen D. Mechanisms of physiological fibrinolysis. Baillières Clin Haematol 1995; 8: 277-290.
78. Myöhänen H., Vaheri A. Regulation and interactions in the activation of cell-associated plasminogen. Cell Mol Life Sci 2004; 61: 2840-2858.
79. Parks WC, Wilson CL, Lopez-Boado YS Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev Immunol 2004; 4: 617-629.
80. Lähteenmäki K., Virkola R., Saren A., Emödy L., Korhonen TK Expression of plasminogen activator pla of Yersinia pestis enhances bacterial attachment to the mammalian extracellular matrix. Infect Immun 1998; 66: 5755-5762.
81. Goguen JD, Bugge T., Degen JL Role of the pleiotropic effects of plasminogen deficiency in infection experiments with plasminogen-deficient mice. Methods 2000; 21: 179-183.
82. Travis J., Salvesen GS Human plasma proteinase inhibitors. Annu Rev Biochem 1983; 52: 655-709.
83. Longstaff C., Thelwell C. Understanding the enzymology of fibrinolysis and improving thrombolytic therapy. FEBS Lett 2005; 579: 3303-3309.
84. Degen JL, Bugge TH, Goguen JD Fibrin and fibrinolysis in infection and host defense. J Thromb Haemost 2007; 5(Suppl 1): 24-31.
85. Flick MJ, Du X., Witte DP et al. Leukocyte engagement of fibrin(ogen) via the integrin receptor alphaMbeta2/Mac-1 is critical for host inflammatory response in vivo. J Clin Invest 2004; 113: 1596-1606.
86. Yun TH, Cott JE, Tapping RI, Slauch JM, Morrissey JH Proteolytic inactivation of tissue factor pathway inhibitor by bacterial omptins. Blood 2008; doi:10.1182/blood-2008-05-157180.
87. Vranckx L., De Buck E., Anne J., Lammertyn E. Legionella pneumophila exhibits plasminogen activator activity. Microbiology 2007; 153: 3757-3765.
88. Maxson-Stein K., McGhee GC, Smith JJ, Jones AL, Sundin GW Genetic analysis of a pathogenic Erwinia sp. isolated from pear in Japan. Phytopathology 2003; 93: 1393-1399.
89. Vassalli JD, Wohlwend A., Belin D. Urokinase-catalyzed plasminogen activation at the monocyte/macrophage cell surface: A localized and regulated proteolytic system. Curr Top Microbiol Immunol 1992; 181: 65-86.
90. Opdenakker G., Van den Steen PE, Dubois B. et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 2001; 69: 851-859.
91. Castaneda FE, Walia B., Vijay-Kumar M. et al. Targeted deletion of metalloproteinase 9 attenuates experimental colitis in mice: Central role of epithelial-derived MMP. Gastroenterology 2005; 129: 1991-2008.
92. Handley SA, Miller VL General and specific host responses to bacterial infection in Peyer's patches: A role for stromelysin-1 (matrix metalloproteinase-3) during Salmonella enterica infection. Mol Microbiol 2007; 64: 94-110.
93. Lijnen HR, Van Hoef B., Collen D. Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1. Biochim Biophys Acta 2001; 1547: 206-213.
94. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001; 17: 463-516.
95. Walport MJ Complement. First of two parts. N Engl J Med 2001; 344: 1058-1066.
96. Ngampasutadol J., Ram S., Blom AM et al. Human C4b-binding protein selectively interacts with Neisseria gonorrhoeae and results in species-specific infection. Proc Natl Acad Sci USA 2005; 102: 17142-17147.
97. Perry RD, Brubaker RR Vwa+ phenotype of Yersinia enterocolitica. Infect Immun 1983; 40: 166-171.
98. Perry RD, Fetherston JD Yersinia pestis - etiologic agent of plague. Clin Microbiol Rev 1997; 10: 35-66.
99. Lathem WW, Crosby SD, Miller VL, Goldman WE Progression of primary pneumonic plague: A mouse model of infection, pathology, and bacterial transcriptional activity. Proc Natl Acad Sci USA 2005; 102: 17786-17791.
100. Janssen WA, Surgalla MJ Plague bacillus: Survival within host phagocytes. Science 1969; 163: 950-952.
101. Straley SC, Harmon PA Growth in mouse peritoneal macrophages of Yersinia pestis lacking established virulence determinants. Infect Immun 1984; 45: 649-654.
102. Charnetzky WT, Shuford WW Survival and growth of Yersinia pestis within macrophages and an effect of the loss of the 47-megadalton plasmid on growth in macrophages. Infect Immun 1985; 47: 234-241.
103. Cowan C., Jones HA, Kaya YH, Perry RD, Straley SC Invasion of epithelial cells by Yersinia pestis: Evidence for a Y. pestis-specific invasin. Infect Immun 2000; 68: 4523-4530.
104. Lähteenmäki K., Kukkonen M., Korhonen TK The Pla surface protease/adhesin of Yersinia pestis mediates bacterial invasion into human endothelial cells. FEBS Lett 2001; 504: 69-72.
105. Pujol C., Bliska JB The ability to replicate in macrophages is conserved between Yersinia pestis and Yersinia pseudotuberculosis. Infect Immun 2003; 71: 5892-5899.
106. Sebbane F., Gardner D., Long D., Gowen BB, Hinnebusch BJ Kinetics of disease progression and host response in a rat model of bubonic plague. Am J Pathol 2005; 166: 1427-1439.
107. Viboud GI, Bliska JB Yersinia outer proteins: Role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 2005; 59: 69-89.
108. Zhang SS, Park CG, Zhang P. et al. The plasminogen activator Pla of Yersinia pestis utilizes murine DEC-205 (CD205) as a receptor to promote dissemination. J Biol Chem 2008; 283: 31511-31521.
109. Benedek O., Nagy G., Emody L. Intracellular signalling and cytoskeletal rearrangement involved in Yersinia pestis plasminogen activator (Pla) mediated HeLa cell invasion. Microb Pathog 2004; 37: 47-54.
110. Lähteenmäki K., Kukkonen M., Jaatinen S. et al. Yersinia pestis Pla has multiple virulence-associated functions. Adv Exp Med Biol 2003; 529: 141-145.
111. Brandenburg K., Garidel P., Schromm AB et al. Investigation into the interaction of the bacterial protease OmpT with outer membrane lipids and biological activity of OmpT:lIpopolysaccharide complexes. Eur Biophys J 2005; 34: 28-41.
112. Guina T., Yi EC, Wang H., Hackett M., Miller SI A PhoPregulated outer membrane protease of Salmonella enterica serovar Typhimurium promotes resistance to alpha-helical antimicrobial peptides. J Bacteriol 2000; 182: 4077-4086.
113. Bader MW, Sanowar S., Daley ME et al. Recognition of antimicrobial peptides by a bacterial sensor kinase. Cell 2005; 122: 461-472.
114. Wehkamp J., Schauber J., Stange EF Defensins and cathelicidins in gastrointestinal infections. Curr Opin Gastroenterol 2007; 23: 32-38.
115. Ayabe T., Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria. Nat Immunol 2000; 1: 113-118.
116. Bishop JL, Finlay BB Friend or foe? Antimicrobial peptides trigger pathogen virulence. Trends Mol Med 2006; 12: 3-6.
117. Galvan EM, Lasaro MA, Schifferli DM Capsular antigen fraction 1 and Pla modulate the susceptibility of Yersinia pestis to pulmonary antimicrobial peptides such as cathelicidin. Infect Immun 2008; 76: 1456-1464.
118. Stumpe S., Schmid R., Stephens DL, Georgiou G., Bakker EP Identification of OmpT as the protease that hydrolyzes the antimicrobial peptide protamine before it enters growing cells of Escherichia coli. J Bacteriol 1998; 180: 4002-4006.
119. O'Loughlin TL, Patrick WM, Matsumura I. Natural history as a predictor of protein evolvability. Protein Eng Des Sel 2006; 19: 439-442.
120. Tamura K., Dudley J., Nei M., Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007; 24: 1596-1599.
121. Marti-Renom MA, Stuart AC, Fiser A., Sanchez R., Melo F., Sali A. Comparative protein structure modeling of genes and genomes. Annu Rev Biophys Biomol Struct 2000; 29: 291-325.
122. Humphrey W., Dalke A., Schulten K. VMD - Visual Molecular Dynamics. J Mol Graphics 1996; 14: 33-38.